Opportunity Information: Apply for RFA OD 12 007
Apply for RFA OD 12 007
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "NIH Revision Applications for Research Relevant to the Family Smoking Prevention and Tobacco Control Act (P30)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.077 Family Smoking Prevention and Tobacco Control Act Regulatory Research.
- This funding opportunity was created on Dec 18, 2012 and posted on Dec 18, 2012.
- Applicants must submit their applications by Mar 26, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $20,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $1,000,000.00 in funding.
- The number of recipients for this funding is limited to 20 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification) Public and State controlled institutions of higher education Private institutions of higher education.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Tribally Controlled Colleges and Universities (TCCUs) Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The NIH funding opportunity RFA-OD-12-007 is a discretionary grant announcement inviting revision applications to existing NIH-supported P30 center grants. The goal is to allow currently funded P30 awardees to broaden or extend the scope of their approved research programs by adding new work that is directly relevant to smoking, tobacco products, and/or tobacco constituents. In practical terms, this is not a brand-new standalone center competition; it is a chance for institutions that already hold an active P30 award to request additional support to expand what their center is doing, specifically in ways that align with federal tobacco regulatory research needs.
A central feature of the announcement is its connection to the Family Smoking Prevention and Tobacco Control Act and the FDA's regulatory authority over tobacco products. Applicants are expected to propose revisions that address research priorities tied to tobacco regulation, such as generating evidence that could inform FDA decisions about product standards, labeling, marketing, product constituents, nicotine delivery, toxicity, addictiveness, and public health impacts. The FOA also makes clear that revisions are welcome even when the original P30 did not focus on tobacco, as long as the proposing team has the scientific expertise to do credible tobacco-related work and the added aims clearly fit the FDA-related priorities described in the announcement.
Eligibility is limited to investigators and institutions with active NIH-funded P30 project awards, including those operating under a funded extension. A range of higher-education institution types may apply, including public and state-controlled universities and private institutions of higher education, as well as several categories of minority-serving institutions (such as HBCUs, Hispanic-serving institutions, Tribal colleges and universities, Alaska Native and Native Hawaiian serving institutions, and AANAPISIs). Foreign institutions are not eligible to apply, and non-U.S. components of U.S. organizations are not eligible; however, foreign components are allowed as defined by the NIH Grants Policy Statement, which typically means specific, justified elements of the work may occur abroad under an eligible U.S. applicant organization.
The announcement anticipated around 20 awards with an estimated total funding level of about $20 million, and it set an award ceiling of $1,000,000. There is no cost sharing or matching requirement, which generally means applicants are not required to commit institutional funds as a condition of receiving the award (though institutions can still provide support if they choose). The activity category is health, and the relevant CFDA number listed is 93.077, reflecting the regulatory research focus connected to the Tobacco Control Act.
Timing details in the posting show it was published on December 18, 2012, with an application due date (closing date) of March 26, 2013, and an archive date of April 26, 2013. While those dates indicate the opportunity was time-limited and is now archived, the summary structure remains useful as a model for understanding what NIH meant by a "revision" to a P30: a targeted expansion of an already-funded center program, justified by an emerging or high-priority scientific and public health need, in this case evidence to support FDA tobacco regulation.
For applicants needing the complete policy and scientific requirements, NIH provided the full FOA via the NIH grants guide at the link in the announcement, and offered support contacts through the NIH Office of Extramural Research (OER) webmaster for access or linking issues.
Frequently Asked Questions (FAQs) - NIH RFA-OD-12-007 (P30 Revision Applications)
What is NIH RFA-OD-12-007?
RFA-OD-12-007 is an NIH discretionary grant announcement that invited revision applications to existing NIH-supported P30 center grants. It was designed to let currently funded P30 centers broaden or extend their approved research programs by adding new work directly relevant to smoking, tobacco products, and/or tobacco constituents.
Is this a new, standalone P30 center competition?
No. This opportunity was not a brand-new standalone center competition. It specifically supported revisions (i.e., expansions) to centers that already had an active NIH-funded P30 award.
What is the main purpose of the revision funding under this announcement?
The purpose was to provide additional support so active P30 awardees could expand their center's scope with new tobacco-related research that aligns with federal tobacco regulatory research needs, especially evidence that could support FDA regulatory decision-making.
How does this opportunity relate to FDA tobacco regulation?
The announcement is tied to the Family Smoking Prevention and Tobacco Control Act and the FDA's regulatory authority over tobacco products. Proposed revisions were expected to address research priorities connected to tobacco regulation and to generate evidence that could inform FDA actions.
What kinds of research topics were encouraged?
The FOA emphasized research that could inform FDA decisions in areas such as product standards, labeling, marketing, product constituents, nicotine delivery, toxicity, addictiveness, and overall public health impacts.
Can a P30 center apply if its original research focus was not tobacco-related?
Yes. The FOA stated that revisions were welcome even when the original P30 did not focus on tobacco, as long as the proposing team had the scientific expertise to conduct credible tobacco-related work and the added aims clearly aligned with the FDA-related priorities described in the announcement.
Who was eligible to apply?
Eligibility was limited to investigators and institutions with active NIH-funded P30 project awards, including centers operating under a funded extension.
Are foreign institutions eligible to apply as the main applicant?
No. Foreign institutions were not eligible to apply under this announcement.
Are non-U.S. components of U.S. organizations eligible?
No. Non-U.S. components of U.S. organizations were not eligible to apply.
Are any foreign activities allowed at all?
Yes, foreign components were allowed as defined by the NIH Grants Policy Statement. This generally means specific, justified elements of the work could occur abroad under an eligible U.S. applicant organization.
What types of U.S. institutions were included as eligible applicants?
A range of higher-education institution types were included, such as public and state-controlled universities and private institutions of higher education, along with multiple categories of minority-serving institutions.
Which minority-serving institutions were specifically mentioned?
The announcement specifically referenced categories including Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribal colleges and universities, Alaska Native and Native Hawaiian serving institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).
How many awards were anticipated and what was the estimated total funding?
The announcement anticipated around 20 awards and estimated a total funding level of about $20 million.
What was the maximum award amount?
The award ceiling listed in the announcement was $1,000,000.
Was cost sharing or matching required?
No. The FOA stated there was no cost sharing or matching requirement. Applicants were not required to commit institutional funds as a condition of receiving the award, although institutions could still provide support voluntarily.
What is the activity category for this opportunity?
The activity category was listed as health.
What CFDA number was associated with this funding opportunity?
The CFDA number listed was 93.077, reflecting the tobacco regulatory research focus connected to the Tobacco Control Act.
When was the opportunity published?
The posting indicated it was published on December 18, 2012.
What was the application due date?
The application due date (closing date) shown was March 26, 2013.
When was the opportunity archived?
The archive date shown was April 26, 2013.
Is this funding opportunity still open?
No. Based on the closing and archive dates provided, the opportunity was time-limited and is now archived.
What does NIH mean by a "revision" to a P30 in this context?
In this context, a revision referred to a targeted expansion of an already funded center program. The added work was expected to be justified by an emerging or high-priority scientific and public health need, specifically evidence to support FDA tobacco regulation.
Where could applicants find the complete FOA requirements?
NIH provided the full FOA through the NIH grants guide link referenced in the announcement.
Who could be contacted for access or linking issues?
The announcement noted support contacts through the NIH Office of Extramural Research (OER) webmaster for access or linking issues.
Browse more opportunities from the same category: Health
Next opportunity: BJA FY 13 Adult Drug Court Discretionary Grant Program
Previous opportunity: FY 2013 National Network for Environmental Management Studies Fellowship Program
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA OD 12 007
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA OD 12 007) also looked into and applied for these:
| Funding Opportunity |
|---|
| Strengthening Disease Prevention Research Capacity for Public Health Action in Guatemala and the Central American Region Apply for RFA GH 13 001 Funding Number: RFA GH 13 001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $20,000,000 |
| Monitoring and Evaluation of Malaria Control and Elimination Activities Apply for RFA GH 13 005 Funding Number: RFA GH 13 005 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| Prevalence and Incidence of Inflammatory Bowel Disease Apply for RFA DP 13 001 Funding Number: RFA DP 13 001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $550,000 |
| NIDCD Small Grant Program (R03) Apply for PAR 13 057 Funding Number: PAR 13 057 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Estimating the Costs of Supporting Primary Care Practice Transformation (R03) Apply for RFA HS 13 003 Funding Number: RFA HS 13 003 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $100,000 |
| Strengthening Public Health and the Public Health Laboratory System of Cambodia under the Presidents Emergency Plan for AIDS Relief Program under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH13 1305 Funding Number: CDC RFA GH13 1305 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $350,000 |
| HIT Capacity Building Initiative for Ryan White HIV/AIDS Program AIDS Drug Assistance Program (ADAP) Grantees Apply for HRSA 13 152 Funding Number: HRSA 13 152 Agency: Health Resources and Services Administration Category: Health Funding Amount: $100,000 |
| R40 MCH Autism Intervention Research Apply for HRSA 13 195 Funding Number: HRSA 13 195 Agency: Health Resources and Services Administration Category: Health Funding Amount: $300,000 |
| Building Systems and Capacity within the Cambodian Ministry of Health to Prevent New HIV Infections and AIDS Related Deaths in Cambodia through PEPFAR Support to the National Center for HIV/AIDS, Dermatology, and STDS (NCHADS) under the Presidents Em Apply for CDC RFA GH13 1303 Funding Number: CDC RFA GH13 1303 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,500,000 |
| Strengthening Global Animal Human Interface Activities for Avian Influenza and other Zoonotic Diseases Apply for RFA CK 13 002 Funding Number: RFA CK 13 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
| Epidemiology, Prevention and Treatment of Influenza and other Respiratory Infections in Panama and Central America Region Apply for RFA IP 13 002 Funding Number: RFA IP 13 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| Grants to States to Support Oral Health Workforce Activities Apply for HRSA 13 142 Funding Number: HRSA 13 142 Agency: Health Resources and Services Administration Category: Health Funding Amount: $500,000 |
| Partnering with the Ministry of Health of Vietnam to Build a Sustainable System for HIV/AIDS Prevention, Care, and Treatment in the Socialist Republic of Vietnam under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH13 1304 Funding Number: CDC RFA GH13 1304 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $12,000,000 |
| NIDCD Clinical Research Center Grant (P50) Apply for PAR 13 062 Funding Number: PAR 13 062 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Nationwide Program for National and State Background Checks for Direct Patient Access Employees of Long Term Care Facilities and Providers Apply for CMS 1A1 13 001 Funding Number: CMS 1A1 13 001 Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: $3,000,000 |
| Interdisciplinary Complementary and Integrative Health Clinical Research Training Award (T90/R90) Apply for PAR 13 065 Funding Number: PAR 13 065 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Strengthening the Monitoring and Evaluation of Programs for the Elimination and Control of Neglected Tropical Diseases in Africa Apply for RFA GH 13 002 Funding Number: RFA GH 13 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $9,000,000 |
| Exemplar Health Information Exchange Governance Entities Program Apply for HIEGE HG 12 001 Funding Number: HIEGE HG 12 001 Agency: Office of the National Coordinator Category: Health Funding Amount: $400,000 |
| Research in latent tuberculosis infection (LTBI) in the setting of HIV Co Infection (R01) Apply for PAR 13 061 Funding Number: PAR 13 061 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Integrating Newborn Screening Long term Follow up into Primary Care Practices Apply for HRSA 13 213 Funding Number: HRSA 13 213 Agency: Health Resources and Services Administration Category: Health Funding Amount: $110,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA OD 12 007", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.